Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) EBITDA (2016 - 2025)

Scienture Holdings (SCNX) has disclosed EBITDA for 13 consecutive years, with -$5.2 million as the latest value for Q2 2025.

  • Quarterly EBITDA fell 244.85% to -$5.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$15.7 million through Jun 2025, down 40.85% year-over-year, with the annual reading at -$9.1 million for FY2025, 38.31% up from the prior year.
  • EBITDA hit -$5.2 million in Q2 2025 for Scienture Holdings, down from -$3.6 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$218763.0 in Q3 2022 to a low of -$5.5 million in Q1 2024.
  • Historically, EBITDA has averaged -$2.0 million across 5 years, with a median of -$1.2 million in 2021.
  • Biggest five-year swings in EBITDA: tumbled 988.85% in 2021 and later soared 83.12% in 2022.
  • Year by year, EBITDA stood at -$782324.0 in 2021, then plummeted by 228.58% to -$2.6 million in 2022, then fell by 29.38% to -$3.3 million in 2023, then soared by 55.03% to -$1.5 million in 2024, then tumbled by 244.85% to -$5.2 million in 2025.
  • Business Quant data shows EBITDA for SCNX at -$5.2 million in Q2 2025, -$3.6 million in Q1 2025, and -$1.5 million in Q2 2024.